| C0006-0002 | Carfilzomib | 868540-17-4 | Parent API (reference standard) |
| C0006-0017 | Carfilzomib Impurity 1 | 1672698-96-2 | Impurity |
| C0006-0022 | Carfilzomib Dimer Impurity 2 | 17-11-8 | Impurity |
| C0006-0031 | Carfilzomib Impurity 5 | 2049025-45-6 | Impurity |
| C0006-0032 | Carfilzomib Impurity 5 (RSSSS) | 254888-44-3 | Impurity |
| C0006-0034 | Carfilzomib Impurity 5 TFA Salt | 1545469-02-0 | Impurity |
| C0006-0038 | Carfilzomib Impurity 8 | 1660143-42-9 | Impurity |
| C0006-0040 | Carfilzomib Impurity 9 | 2049025-76-3 | Impurity |
| C0006-0048 | Carfilzomib Impurity 13 HCl | 1396006-45-3 | Impurity |
| C0006-0049 | Carfilzomib Impurity 14 | 1396006-47-5 | Impurity |
| C0006-0057 | Carfilzomib Impurity 19 | 2381627-87-6 | Impurity |
| C0006-0062 | Carfilzomib Impurity 22 | 3235-69-6 | Impurity |
| C0006-0076 | Carfilzomib Impurity 34 | 2049024-77-1 | Impurity |
| C0006-0078 | Carfilzomib Impurity 35 | 2049024-62-4 | Impurity |
| C0006-0081 | Carfilzomib Impurity 37 | 254888-42-1 | Impurity |
| C0006-0084 | Carfilzomib Impurity 39 | 2049025-59-2 | Impurity |
| C0006-0086 | Carfilzomib Impurity 40 | 1672698-88-2 | Impurity |
| C0006-0088 | Carfilzomib Impurity 41 | 2049025-67-2 | Impurity |
| C0006-0090 | Carfilzomib Impurity 42 | 2049025-49-0 | Impurity |
| C0006-0092 | Carfilzomib Impurity 43 | 1140908-89-9 | Impurity |
| C0006-0094 | Carfilzomib Impurity 44 | 247068-85-5 | Impurity |
| C0006-0106 | Carfilzomib Impurity 55 | 2049025-83-2 | Impurity |
| C0006-0124 | Carfilzomib Impurity 64 | 1809093-03-5 | Impurity |
| C0006-0134 | Carfilzomib Impurity 69 | 1541171-68-9 | Impurity |
| C0006-0135 | Carfilzomib Impurity 70 | 1672699-03-4 | Impurity |
| C0006-0138 | Carfilzomib Impurity 71 | 2436762-87-5 | Impurity |
| C0006-0140 | Carfilzomib Impurity 72 | 1528769-14-3 | Impurity |
| C0006-0142 | Carfilzomib Impurity 73 | 1469982-99-7 | Impurity |
| C0006-0144 | Carfilzomib Impurity 74 | 2443766-79-6 | Impurity |
| C0006-0152 | Carfilzomib Impurity 81 | 100564-78-1 | Impurity |
| C0006-0153 | Carfilzomib Impurity 82 | 2419266-61-6 | Impurity |
| C0006-0156 | Carfilzomib Impurity 83 | 2419266-66-1 | Impurity |
| C0006-0161 | Carfilzomib Impurity 85 | 2049024-67-9 | Impurity |
| C0006-0173 | Carfilzomib Impurity 93 | 5874-73-7 | Impurity |
| C0006-0178 | Carfilzomib Impurity 99 | 2559766-56-0 | Impurity |
| C0006-0180 | Carfilzomib Impurity 100 | 2556763-77-8 | Impurity |
| C0006-0182 | Carfilzomib Impurity 101 | 3063-05-6 | Impurity |
| C0006-0190 | Carfilzomib Impurity 107 | 1140908-90-2 | Impurity |
| C0006-0197 | Carfilzomib-d8 | 1537187-53-3 | Stable-isotope labelled analogue |
| C0006-0255 | ((S)-2-((tert-butoxycarbonyl)amino)-4-phenylbutanoyl)-L-leucyl-L-phenylalanine | 1545469-01-9 | Related substance |
| C0006-0256 | ((S)-2-(2-morpholinoacetamido)-4-phenylbutanoyl)-L-leucyl-L-phenylalanine | 868540-16-3 | Related substance |
| C0006-0258 | ((S)-2-Amino-4-phenylbutanoyl)-L-aspartic Acid | 3066865-52-6 | Related substance |
| C0006-0259 | ((S)-2-amino-4-phenylbutanoyl)-L-leucyl-L-phenylalanine | 1545468-80-1 | Related substance |
| C0006-0266 | (2R)-2-Amino-4-methyl-1-[(2R)-2-methyl-2-oxiranyl]-1-pentanone | 2049023-98-3 | Related substance |
| C0006-0285 | (2S)-N-((1S)-1-(5-(1-hydroxyethyl)-4-isobutyloxazol-2-yl)-2-phenylethyl)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide | 1890999-53-7 | Isomer |
| C0006-0293 | (2S)-N-[(2S)-1-[[(2R,4S)-1,2-dihydroxy-2,6-dimethyl-3-oxoheptan-4-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methyl-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide | 1541172-75-1 | Related substance |
| C0006-0298 | (2S,3S)-2-amino-3-methyl-1-[(2R)-2-methyloxiran-2-yl]pentan-1-one | 1796585-29-9 | Related substance |
| C0006-0299 | (2S,4S)-4-Amino-2-hydroxy-2,6-dimethyl-3-oxoheptyl Acetate Trifluoroacetic Acid Salt | 2518419-39-9 | Related substance |
| C0006-0302 | (3S,6S)-3-benzyl-6-(2-methylpropyl)piperazine-2,5-dione | 7280-77-5 | Related substance |
| C0006-0310 | (6S,9S,12S)-Benzyl 12-Benzyl-6-(2-cyclohexylethyl)-9-isobutyl-2,2-dimethyl-4,7,10-trioxo-3-oxa-5,8,11-triazatridecan-13-oate | 2768679-89-4 | Isomer |
| C0006-0316 | (R)-4-Methyl-N-((R)-1-(((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide | 2803420-45-1 | Related substance |
| C0006-0326 | (R)-t-Butyl (2,6-Dimethyl-3-oxohept-1-en-4-yl)carbamate | 2177287-70-4 | Related substance |
| C0006-0330 | (S)-2-((S)-2-((S)-2-Acetamido-4-phenylbutanamido)-4-methylpentanamido)-3-phenylpropanoic acid | 890660-08-9 | Related substance |
| C0006-0332 | (S)-2-((S)-2-((tert-butoxycarbonyl)amino)-4-phenylbutanamido)-4-phenylbutanoic acid | 1437782-22-3 | Related substance |
| C0006-0337 | (S)-2-((tert-butoxycarbonyl)amino)-4-cyclohexylbutanoic acid | 143415-51-4 | Related substance |
| C0006-0338 | (S)-2-aMino-4-Methyl-1-((R)-2-Methyloxiran-2-yl)pentan-1-one | 247068-84-4 | Related substance |
| C0006-0339 | (S)-2-amino-4-methyl-1-((S)-2-methyloxiran-2-yl)pentan-1-one | 1528769-13-2 | Related substance |
| C0006-0341 | (S)-2-amino-N-((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)-3-phenylpropanamide | 1469983-03-6 | Related substance |
| C0006-0343 | (S)-4-amino-2,6-dimethylhept-1-en-3-one 2,2,2-trifluoroacetate | 1619233-32-7 | Related substance |
| C0006-0345 | (S)-4-methyl-N-((R)-1-(((R)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2-((R)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide | 2803377-12-8 | Related substance |
| C0006-0346 | (S)-4-methyl-N-((R)-1-(((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2-((R)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide | 2419266-62-7 | Related substance |
| C0006-0353 | (S)-4-methyl-N-((S)-1-(((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide maleate | 1960444-12-5 | Salt / salt form |
| C0006-0354 | (S)-4-Methyl-N-((S)-4-methyl-1-(((S)-1-(((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)amino)-1-oxopentan-2-yl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide | 1960444-14-7 | Related substance |
| C0006-0356 | (S)-benzyl 2-((S)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoate | 875309-92-5 | Related substance |
| C0006-0359 | (S)-methyl 2-((S)-2-((R)-2-amino-4-phenylbutanamido)-4-methylpentanamido)-3-phenylpropanoate | 2419266-56-9 | Related substance |
| C0006-0366 | (S)-N-((S)-1-(((2R,4S)-2-chloro-1-hydroxy-2,6-dimethyl-3-oxoheptan-4-yl)amino)-1-oxo-3-phenylpropan-2-yl)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide | 1890999-52-6 | Related substance |
| C0006-0371 | (S)-N-((S)-1-(((2S,4S)-1,2-Dihydroxy-2,6-dimethyl-3-oxoheptan-4-yl)amino)-1-oxo-3-phenylpropan-2-yl)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide Hydrochloride | 868539-98-4 | Salt / salt form |
| C0006-0379 | (tert-butoxycarbonyl)-D-leucine | 16937-99-8 | Related substance |
| C0006-0380 | (tert-butoxycarbonyl)-L-leucine | 13139-15-6 | Related substance |
| C0006-0381 | (αS)-α-Amino-γ-oxo-benzenebutanoic Acid Hydrochloride | 168154-76-5 | Salt / salt form |
| C0006-0403 | 4-Amino-1,2-anhydro-4,5,6,7-tetradeoxy-5-methyl-2-C-methyl-L-ribo-3-heptulose 2,2,2-Trifluoroacetate | 1800500-63-3 | Related substance |
| C0006-0404 | 4-Methyl-2-(2-(2-morpholinoacetamido)-4-phenylbutanamido)-N-(1-oxo-3-phenyl-1-((1,2,2-trihydroxy-6-methyl-3-oxoheptan-4-yl)amino)propan-2-yl)pentanamide | 1541171-67-8 | Related substance |
| C0006-0406 | 4-Phenylbutanoic Acid Hydrochloride, (S)-2-(2-morpholinoacetamido)- | 2319881-95-1 | Salt / salt form |
| C0006-0411 | Benzenebutanoic acid, α-[[(2S)-2-amino-1-oxo-4-phenylbutyl]amino]-, (αS) | 1927872-86-3 | Related substance |
| C0006-0416 | benzyl ((S)-2-((tert-butoxycarbonyl)amino)-4-phenylbutanoyl)-L-leucyl-D-phenylalaninate | 2049024-27-1 | Related substance |
| C0006-0418 | Benzyl ((S)-2-Amino-4-phenylbutanoyl)-L-leucyl-L-phenylalaninate | 875309-82-3 | Related substance |
| C0006-0419 | benzyl (2S)-2-[[(2R)-4-methyl-2-[[(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-4-phenylbutanoyl]amino]pentanoyl]amino]-3-phenylpropanoate | 2049024-22-6 | Related substance |
| C0006-0423 | benzyl (2S)-2-[[(2S)-4-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoyl]amino]-3-phenylpropanoate | 70637-26-2 | Related substance |
| C0006-0424 | benzyl (2S)-2-[[(2S)-4-methyl-2-[[(2R)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-4-phenylbutanoyl]amino]pentanoyl]amino]-3-phenylpropanoate | 2049024-37-3 | Related substance |
| C0006-0425 | benzyl (2S)-2-[[(2S)-4-methyl-2-[[(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-4-phenylbutanoyl]amino]pentanoyl]amino]-3-phenylpropanoate | 868540-15-2 | Related substance |
| C0006-0427 | benzyl L-leucyl-L-phenylalaninate | 70637-27-3 | Related substance |
| C0006-0429 | Carfilzomib (2R,4S)-2-Hydroxy Acetate | 1541171-69-0 | Related substance |
| C0006-0441 | CarfilzoMib IMpurity | 1541171-65-6 | Impurity |
| C0006-0444 | D-Phenylalanine, N-[(1,1-diMethylethoxy)carbonyl]-L-leucyl-, Methyl ester | 15136-32-0 | Related substance |
| C0006-0446 | L-Phenylalaninamide, (αS)-α-[[2-(4-morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-N-[(1S)-3,4-dihydroxy-3-methyl-1-(2-methylpropyl)-2-oxobutyl] | 1396006-50-0 | Related substance |
| C0006-0447 | L-Phenylalaninamide, (αS)-α-[[2-(4-morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyl-2-oxiranyl]carbonyl]butyl]-, labeled with Deuterium | 1803132-11-7 | Stable-isotope labelled analogue |
| C0006-0448 | L-Phenylalanine, N-L-leucyl-, methyl ester | 38155-18-9 | Related substance |
| C0006-0451 | methyl (2S)-2-[[(2S)-2-[[(2S)-2-amino-4-phenylbutanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoate | 868539-99-5 | Related substance |
| C0006-0452 | methyl (2S)-2-[[(2S)-4-methyl-2-[[(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-4-phenylbutanoyl]amino]pentanoyl]amino]-3-phenylpropanoate | 868539-96-2 | Related substance |
| C0006-0453 | Morpholin-4-yl-acetic acid hydrochloride | 89531-58-8 | Salt / salt form |
| C0006-0455 | N-[(1R)-1-[(Methoxymethylamino)carbonyl]-3-methylbutyl]-carbamic Acid 1,1-Dimethylethyl Ester | 129603-01-6 | Related substance |
| C0006-0456 | N-[(1S)-1-[(Dimethylamino)carbonyl]-3-methylbutyl]-carbamic Acid 1,1-Dimethylethyl Ester | 72080-89-8 | Related substance |
| C0006-0457 | N-[(1S)-2-Hydroxy-3-methyl-1-(2-methylpropyl)-3-buten-1-yl]-carbamic Acid 1,1-Dimethylethyl Ester | 1609959-45-6 | Related substance |
| C0006-0458 | N-[4-[[2-(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-α-methyl-2-oxo-1(2H)-pyrimidineacetamide | 943238-68-4 | Related substance |
| C0006-0459 | N-Des-4-morpholineacetic Acid N-Boc-Carfilzomib | 868540-22-1 | Related substance |
| C0006-0461 | Carfilzomib Impurity 10 | 290298-02-1 | Impurity |
| C0006-0469 | Pentanamide, 2-amino-N-methoxy-N,4-dimethyl-, (2S) | 102837-29-6 | Related substance |
| C0006-0472 | Tert-butyl ((4R)-3-hydroxy-2,6-dimethylhept-1-en-4-yl)carbamate | 2145198-41-8 | Related substance |
| C0006-0474 | tert-Butyl ((S)-1-(((S)-4-methyl-1-(((S)-1-(((R)-4-methyl-1-((S)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)amino)-1-oxopentan-2-yl)amino)-1-oxo-4-phenylbutan-2-yl)carbamate | 2049025-27-4 | Related substance |
| C0006-0476 | tert-butyl N-[(2R)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]carbamate | 2177287-68-0 | Related substance |
| C0006-0478 | tert-butyl N-[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]carbamate | 247068-82-2 | Related substance |
| C0006-0479 | tert-butyl N-[(2S)-4-methyl-1-[(2S)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]carbamate | 247068-83-3 | Related substance |
| C0006-0480 | tert-butyl N-[(4S)-2,6-dimethyl-3-oxohept-1-en-4-yl]carbamate | 247068-81-1 | Related substance |